Navigation Links
Examining the Lacey Act
Date:9/11/2007

Andrea Fowler, David Lodge, and Jennifer Hsia (University of Notre Dame) examined the efficacy of the Lacey Act in their research communication, Failure of the Lacey Act to protect US ecosystems against animal invasions. The study appears in the September issue of Frontiers in Ecology and the Environment.

With over 100 years on the books (passed in 1900), the Lacey Act is the main legal defense against invasive animal species. The injurious wildlife provision of the Lacey Act seeks to regulate foreign invasive species that may damage ecosystems, replace native populations, and kill off valuable natural resources and fisheries.

If the US is to reduce the probability of future damage from invasive animal species, revision or replacement of the Lacey Acts injurious wildlife provision is essential, say the authors. The contemporary threat of invasive species has far outstripped current authority and practice under this statute.

Examining all Federal Register documents, Fowler and colleagues searched the listed names of organisms, references to the Lacey Act, and references to injurious wildlife to determine which species were listed, considered for listing, and either added or not added to the list.

Many animals were already established when they were added to the list and continued to spread after their listing. The most common way to begin the process of listing a species in the last 25 years has been by petitioning the U.S. Fish and Wildlife Service. However, by March 1, 2007, when the authors wrote the paper, it took an average of more that three and a half years to list a species in this way.

According to the report, the lack of an efficient and consistently applied risk assessment procedure undermine the Lacey Act. Currently, most imported species only need to be declared to customs or permitted through the US Fish and Wildlife Service. The act was expanded from mammals and birds to include mollusks, crustaceans, reptiles, and amphibians in the late 1960s and early 1980s. In the 1970s there was a movement to limit importation to a list of low-risk wildlife, but the list was never implemented.

Fowler et. al. point out that the Lacey Act contains no authority or funding to manage the spread of established wild invasive species, which will do little to slow down organisms already present in the US.

The researchers suggest that prescreening, as well as switching from the use of a list of banned animals to approved species, would better protect the nations environment and natural resources.


'/>"/>

Contact: Annie Drinkard
annie@esa.org
Ecological Society of America
Source:Eurekalert

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
Breaking Biology Technology: